315 results on '"Becker, Richard"'
Search Results
2. Quantitative structure use relationships: Highlights from a technical summit meeting
3. Can a best practice advisory improve anticoagulation prescribing to reduce stroke risk in patients with atrial fibrillation?
4. MANAGEMENT OF HIGH OUTPUT HEART FAILURE IN HEREDITARY HEMORRHAGIC TELANGIECTASIA
5. Best practices for exposure model peer review – A SciPinion advisory panel report
6. Temporal scale-bridging of chemistry in a multiscale model: Application to reactivity of an energetic material
7. Genetic ablation of diabetes-associated gene Ccdc92 reduces obesity and insulin resistance in mice
8. Can the Predictive Analytics Toolkit (PAT) handle a genomic data set?
9. Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes
10. Multiscale modeling of 3D nano-architected materials under large deformations
11. Racial and sex differences in optimizing anticoagulation therapy for patients with atrial fibrillation
12. Electronic health record-embedded decision support to reduce stroke risk in patients with atrial fibrillation – Study protocol
13. THE CINCINNATI ATRIAL FIBRILLATION SCORE (CAFS): MULTICENTER VALIDATION OF THE FIRST POLYSOMNOGRAPHY-BASED RISK SCORE FOR PREDICTING INCIDENT ATRIAL FIBRILLATION IN ASYMPTOMATIC AMBULATORY COMMUNITY ADULTS
14. Genetic Ablation of CCDC92 Protects against Vascular Inflammation and Atherosclerosis
15. Parallel tunnel channels of the Huron-Erie Lobe of the Laurentide Ice Sheet: A variation of tunnel channels with implications on lobe history and subglacial meltwater dynamics
16. Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
17. Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF
18. Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF
19. Evaluating management options to reduce Lake Erie algal blooms using an ensemble of watershed models
20. Void growth dependence on loading path and mean stress from large-scale numerical simulations
21. Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve
22. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
23. The potential roles of Von Willebrand factor and neutrophil extracellular traps in the natural history of hypertrophic and hypertensive cardiomyopathy
24. The hydrologic model as a source of nutrient loading uncertainty in a future climate
25. Recommendations for further revisions to improve the International Agency for Research on Cancer (IARC) Monograph program
26. 21st Century Approaches for Evaluating Exposures, Biological Activity, and Risks of Complex Substances: Workshop highlights
27. Designing Human In Vitro Models for Drug Development
28. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay
29. ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial
30. The Predictive Analytics Toolkit (PAT): User-friendly predictive analytics for advancing new approach methodologies (NAMs)
31. Ticagrelor in patients with heart failure after acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
32. Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels
33. Unmanned aerial system based spectroradiometer for monitoring harmful algal blooms: A new paradigm in water quality monitoring
34. Transforming regulatory safety evaluations using New Approach Methodologies: A perspective of an industrial toxicologist
35. Evaluating visible derivative spectroscopy by varimax-rotated, principal component analysis of aerial hyperspectral images from the western basin of Lake Erie
36. BRUGADA PHENOCOPY UNMASKED AFTER A MOTOR VEHICLE ACCIDENT
37. Anticoagulants
38. Utilizing Threshold of Toxicological Concern (TTC) with high throughput exposure predictions (HTE) as a risk-based prioritization approach for thousands of chemicals
39. Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis
40. Accelerated scale-bridging through adaptive surrogate model evaluation
41. Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF
42. Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF
43. How well can carcinogenicity be predicted by high throughput “characteristics of carcinogens” mechanistic data?
44. Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)
45. Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)
46. Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial
47. Brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism is associated with disease severity and incidence of cardiovascular events in a patient cohort
48. Increased Post-procedural Non-gastrointestinal Adverse Events After Outpatient Colonoscopy in High-risk Patients
49. Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial)
50. Quantitative weight of evidence to assess confidence in potential modes of action
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.